# Emergent BioSolutions Inc.: Form 8-K, filed Jun 8, 2020

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2020-06-08
- Accepted by EDGAR: Jun 8, 2020, 06:29 ET
- Period: 2020-06-05
- Accession: 0001367644-20-000104
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764420000104/ebs-2020x06x08pressrel.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764420000104/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764420000104/ebs-2020x06x08pressrel.htm

Filed Jun 8, 2020.
Source: SEC EDGAR, the filing index for accession 0001367644-20-000104. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
